Tim Opler@TimOplerFeb 3, 2023Replying to @BertrandBio @BiotechCH and 8 othersFive ways biopharma companies can navigate the deal landscapeFrom mckinsey.com333314143.1K3.1K
Tim Opler@TimOplerJan 8, 2025Replying to @damienics and @bradloncarstifel.com/Newsletters/In…22111313660660
